Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on
About Palatin
Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential.
Contact:
Email: info@palatin.com
(C) 2023 Electronic News Publishing, source